USPTO serial 79194037
PRISMACCESS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- MORRIS, KRISTINA KLOIBER
- Law office
- TTAB
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with PRISMACCESS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
JONATHAN Z KING
JONATHAN Z KING COWAN LIEBOWITZ & LATMAN PC114 WEST 47TH STREETNEW YORK, NY 10036UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Software being recorded programs for use in database management, management and classification of pharmaceutical information and data; software and applications for mobile devices for use in database management, management and classification of pharmaceutical information and data; data communication software for providing scientific and/or economic and/or legal information and data on pharmaceutical proprietary products; computer software for use in data collection, data management and data analysis of pharmaceutical, medical, health-economy and healthcare information ; computer software for use in data collection in the fields clinical trials analysis, market access and Health Technology Assessment (HTA) decisions, Price and Reimbursement (PandR) decisions; computer software for web-based access to data, data collection, data analysis, data integration and preparation of reports in connection with pharmaceutical, medical and health information; downloadable computer software in the form of mobile applications for web-based access to data, data collection, data analysis, data integration and preparation of reports in connection with pharmaceutical, medical and health information | ABANDONED | — |
| 016 | Printing products being printed matter, namely, leaflets, posters and brochures providing pharmaceutical data, whether scientific, legal, regulatory and/or economic to the pharmaceutical industry; printed instructional or teaching material except apparatus in the field of delivering pharmaceutical data, whether scientific, legal, regulatory and/or economic to medical practitioners and members of the pharmaceutical industry; newspapers | ABANDONED | — |
| 035 | Business management and business consultation in the pharmaceutical, medical, and healthcare fields; business consultation in the field of clinical research and clinical trials, namely, assist pharmaceutical companies with clinical trials approval issues for medicinal products and medical devices; business consultation in the field of market access and submission management, namely, assist pharmaceutical companies on Health Technology Assessment (HTA) and Pricing and Reimbursement (PandR) procedures for medicinal products and medical devices; consultation in the field of data processing and database management services for collection of scientific, economic and regulatory data in the field of medicinal products and medical devices; web-based portal providing business information on medicinal products and medical devices, namely, marketing activities and launching strategies; computerized data management in the pharmaceutical, medical, and healthcare fields; computerized file management in the pharmaceutical, medical, and healthcare fields | ABANDONED | — |
| 041 | Education services, namely, workshops, webinars, seminars, expert's panel discussions in the field of pharmaceutical data, whether medical, legal, regulatory and/or economic; providing training in the field of understanding and collecting pharmaceutical data, whether medical, legal, regulatory and/or economic; organization and conducting of educational colloquiums, conferences or congresses in the field of understanding and collecting pharmaceutical data, whether medical, legal, regulatory and/or economic | ABANDONED | — |
| 042 | Software design; research and development of new products for others; technical project studies in the field of new technologies in the field of pharmaceutical data; software maintenance; software installation; software rental; updating of software; scientific and technological analyses, namely, scientific and technological consultancy in relation to the development, validation, and regulatory approval of pharmaceutical drugs, biologics, and medical devices; scientific and technological analyses, namely, scientific and technological consultancy on Health Technology Assessment (HTA), clinical development, Pricing and Reimbursement (PandR) strategies, scientific, legal, regulatory and economic information on pharmaceutical drugs, biologics, and medical devices; design of computer software featuring decision-making tools for the pharmaceutical industry on pharmaceutical drugs, biologics, and medical devices; design of computer systems in the pharmaceutical, medical, and healthcare fields; on-line interactive database featuring scientific research information, on pharmaceutical drugs, biologics, and medical devices in the pharmaceutical, medical, and healthcare fields; technical data analysis services, namely, data mining in the field of pharmaceutical data, whether scientific, legal, regulatory and/or economic; advice relating to information technology intended for the pharmaceutical and health industries | ABANDONED | — |
| 044 | Providing medical, pharmaceutical, health management, and disease management information relating to pharmaceutical products to others | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by IQVIA Operations France SAS
- Other trademarks owned by PRIORITIS, SAS
- Other trademarks owned by PRIORITIS, SAS
- Other trademarks in Class 009
- Other trademarks in Class 016
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named PRISMACCESS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 30, 2025 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Nov 22, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 5, 2023 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 14, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 14, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 14, 2022 | MAB4 | ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION | — |
| Feb 14, 2022 | ABN4 | ABANDONMENT - AFTER INTER PARTES DECISION | — |
| Feb 14, 2022 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Feb 14, 2022 | OP.S | OPPOSITION SUSTAINED NO. 999999 | — |
| May 3, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 26, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 15, 2019 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Apr 12, 2019 | OPNS | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB | — |
| Apr 12, 2019 | OPNC | OPPOSITION NOTICE (IB REFUSAL) CREATED | — |
| Apr 11, 2019 | OPPF | OPPOSITION PAPERS RECEIVED AT TTAB | — |
| Mar 12, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 12, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 20, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 20, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 20, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 5, 2019 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 3, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jan 22, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 21, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 21, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 21, 2019 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 9, 2018 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 9, 2018 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 9, 2018 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 13, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 13, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 13, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 6, 2018 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 21, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 21, 2018 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 9, 2018 | RFNP | REFUSAL PROCESSED BY IB | — |
| Jan 13, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 13, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 13, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 22, 2017 | MREI | NOTICE OF REINSTATEMENT MAILED | — |
| Dec 20, 2017 | REIN | REINSTATED | — |
| Dec 20, 2017 | PCGR | PETITION TO DIRECTOR GRANTED | — |
| Dec 4, 2017 | APET | ASSIGNED TO PETITION STAFF | — |
| Aug 31, 2017 | TPDR | TEAS PETITION TO DIRECTOR RECEIVED | — |
| Jul 6, 2017 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 3, 2017 | MAB0 | ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE | — |
| Jul 3, 2017 | ABN0 | ABANDONMENT - INCOMPLETE RESPONSE | — |
| May 15, 2017 | NAUD | NOTICE OF UNRESPONSIVE AMENDMENT - MAILED | — |
| May 15, 2017 | NAUD | REPORT UNRESPONSIVE AMENDMENT - COMPLETED | — |
| Apr 25, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 25, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 25, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 18, 2016 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 28, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 28, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 28, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 27, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 25, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 21, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 21, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 20, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |